Experience
Abbott Biotechnology Ltd.
Centocor Ortho Biotech Inc.
Represented AbbVie in a validity and infringement dispute involving Humira® (human therapeutic antibodies), one of the best selling drugs in the world. The case settled favorably.
Abbott Biotechnology Ltd. v. Centocor Ortho Biotech Inc., 4:09-cv-40089, D. Mass., Judge Saylor
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
Medtronic Vascular Inc. v. Abbott Vascular, Inc.
Abbott Vascular, Inc.
Hybritech Inc. v. Abbott Laboratories
Hybritech Inc.
Sandoz Inc. v. AbbVie Biotechnology, Ltd
AbbVie Biotechnology, Ltd
Finnegan client AbbVie secures non-institution decisions for Humira® patents
AbbVie Biotechnology, Ltd
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
LG Electronics, Inc. v. Hitachi, Ltd.
LG Electronics
Monolithic Power Systems, Inc. v. O2 Micro International Ltd.
Monolithic Power Systems, Inc.
AbbVie secures four non-institution decisions for Humira® patent
AbbVie Biotechnology, Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.